Chancellor Rachel Reeves Plans Specific Measures on Bills in Forthcoming Financial Plan
Treasury head Rachel Reeves has announced she is planning "specific measures to deal with household expense pressures" in next month's financial statement.
In comments to media outlets, she noted that curbing price rises is a collective duty of both the administration and the Bank of England.
The UK's price growth is forecast to be the highest among the Group of Seven advanced economies this year and the following year.
Potential Energy Bill Measures
It is understood the government could take action to reduce utility costs, such as by cutting the present 5% rate of value-added tax charged on energy.
Another approach is to reduce some of the regulatory levies presently added to household expenses.
Fiscal Constraints and Analyst Predictions
The administration will obtain the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these measures.
The expectation from the majority of analysts is that Reeves will have to introduce tax increases or spending cuts in order to meet her declared borrowing rules.
Earlier on the same day, analysis suggested there was a twenty-two billion pound deficit for the chancellor to fill, which is at the more modest range of forecasts.
"It is a shared task between the Bank of England and the administration to further reduce some of the sources of price increases," the Chancellor stated to the BBC in the US capital, at the annual meetings of the International Monetary Fund and World Bank.
Tax Commitments and International Concerns
While a great deal of the attention has been on probable tax increases, the chancellor said the most recent figures from the OBR had not altered her commitment to manifesto promises not to increase tax levels on income tax, sales tax or National Insurance.
She blamed an "unpredictable world" with rising geopolitical and trade issues for the Budget tax moves, probably to be targeted on those "most able to pay."
Global Economic Tensions
Commenting on worries about the United Kingdom's commercial links with the Asian nation she said: "Our national security always come first."
Recent declaration by Chinese authorities to strengthen export controls on critical minerals and other materials that are key for high-technology manufacturing led US President Donald Trump to threaten an additional 100% import tax on imports from the Asian country, increasing the prospect of an all-out trade war between the two largest economies.
The American finance chief described China's move "commercial pressure" and "a international production control attempt."
Questioned on accepting the US offer to participate in its dispute with China, the Chancellor said she was "deeply worried" by China's measures and encouraged the Chinese government "not to put up barriers and limit trade."
She said the decision was "damaging for the world economy and causes additional challenges."
"In my view there are fields where we should challenge Chinese policies, but there are also significant chances to export to Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that equilibrium appropriate."
The chancellor also stated she was cooperating with other major economies "on our own critical minerals plan, so that we are more independent."
Health Service Medicine Pricing and Investment
Reeves also recognized that the price the National Health Service pays for drugs could rise as a result of ongoing negotiations with the Trump administration and its drugs companies, in return for reduced taxes and funding.
Some of the biggest global drug companies have said lately that they are either delaying or canceling investments in the UK, with some blaming the modest returns they are obtaining.
Recently, the government science advisor said the price the health service pays for medicines would have to go up to prevent businesses and drug research funding departing from the UK.
Reeves told media: "It has been observed due to the cost structure, that drug testing, new drugs have not been available in the United Kingdom in the extent that they are in other European countries."
"Our aim is to ensure that individuals getting treatment from the National Health Service are can receive the best essential drugs in the world. And so we are examining these issues, and... aiming to secure additional funding into the UK."